Taejon, South Korea

Yong-Zu Kim

This inventor holds 3 USPTO granted patents. Top assignee: Lg Life Sciences, Limited. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong-Zu Kim. Retrieved from https://idiyas.com/inventor/yong-zu-kim-ki5cdz84

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Yuseong-gu, KR (2007)
  • Taejeon, KR (2009 - 2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yong-Zu Kim: Innovator in Antiviral Agents

Introduction

Yong-Zu Kim is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of antiviral agents, particularly in the development of acyclic nucleoside phosphonate derivatives. With a total of 3 patents to his name, his work has the potential to impact the treatment of viral infections.

Latest Patents

One of his latest patents is focused on acyclic nucleoside phosphonate derivatives, which are useful as antiviral agents, especially against the hepatitis B virus. This invention includes pharmaceutically acceptable salts and stereoisomers, along with a detailed process for their preparation. The patent outlines a specific formula that includes various chemical groups, demonstrating the complexity and innovation behind his work.

Career Highlights

Yong-Zu Kim is currently associated with LG Life Sciences, Limited, where he continues to advance his research in the pharmaceutical field. His expertise in antiviral agents has positioned him as a key figure in the development of new therapeutic options.

Collaborations

He has collaborated with notable coworkers such as Tae-Kyun Kim and Seung-Joo Cho, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yong-Zu Kim's contributions to antiviral research through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…